HomeNDC LookupRxCUI directory › RxCUI 630714

Camphor 0.03 MG/MG / menthol 0.03 MG/MG Topical Gel — RxCUI 630714

RxNorm drug concept · Semantic clinical drug
RxCUI 630714 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 20 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI630714
Official nameCamphor 0.03 MG/MG / menthol 0.03 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascamphor 3 % / menthol 3 % Topical Gel
FDA products mapped6
Package NDCs mapped20
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Menthol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Menthol is found in a lot of over-the-counter topical products — creams, gels, patches, sprays, and powders. Depending on the product, it's used to temporarily ease minor muscle an...
  • Start with clean, dry skin — free of lotions or creams — before applying the patch. Peel the backing off and press the sticky side firmly to the sore area. Most menthol patches sho...
  • Yes, a mild burning or tingling feeling right after applying a menthol product is common and usually settles down within a few days of regular use. What's not normal is severe burn...
  • Is that burning sensation after I apply it normal?
📖 Read our full Menthol guide →

🕸️ Concept Web — How Camphor 0.03 MG/MG / menthol 0.03 MG/MG Topical... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Camphor 0.03 MG/MG / menthol 0.03 MG/MG Topical Gel RxCUI 630714

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Camphor 1952
    • Menthol 6750
    • Camphor / menthol 466600
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • SOMBRA Warm Pain Relieving Gel 1090951
    • Sore No More 1372555
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Camphor / menthol Topical Gel 378021
    • Camphor / menthol Topical Product 1155407
    • Camphor / menthol Topical Gel [SOMBRA Warm Pain Relieving Gel] 1090953
    • Camphor / menthol Topical Gel [Sore No More] 1372557
    • SOMBRA Warm Pain Relieving Gel Topical Product 1184182
    • Sore No More Topical Product 1372558
    • Topical Gel 346286
    • Topical Product 1151122
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Camphor 0.03 MG/MG 581458
    • Menthol 0.03 MG/MG 329980
    • Camphor 0.03 MG/MG / menthol 0.03 MG/MG Topical Gel [SOMBRA Warm Pain Relieving Gel] 1090954
    • Camphor 0.03 MG/MG / menthol 0.03 MG/MG Topical Gel [Sore No More] 1372559
    • Camphor 0.03 MG/MG / menthol 0.03 MG/MG [SOMBRA Warm Pain Relieving Gel] 1090952
    • Camphor 0.03 MG/MG / menthol 0.03 MG/MG [Sore No More] 1372556

Showing up to 8 concepts per family — 19 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Camphor 0.03 MG/MG SCDC · 581458
  • Menthol 0.03 MG/MG SCDC · 329980
  • Camphor / menthol Topical Gel SCDF · 378021
  • Camphor / menthol Topical Product SCDG · 1155407

Brand-Name Concepts

  • Camphor 0.03 MG/MG / menthol 0.03 MG/MG Topical Gel [Sore No More] SBD · 1372559
  • Camphor 0.03 MG/MG / menthol 0.03 MG/MG Topical Gel [SOMBRA Warm Pain Relieving Gel] SBD · 1090954
  • Camphor 0.03 MG/MG / menthol 0.03 MG/MG [SOMBRA Warm Pain Relieving Gel] SBDC · 1090952
  • Camphor 0.03 MG/MG / menthol 0.03 MG/MG [Sore No More] SBDC · 1372556
  • Camphor / menthol Topical Gel [SOMBRA Warm Pain Relieving Gel] SBDF · 1090953
  • Camphor / menthol Topical Gel [Sore No More] SBDF · 1372557
  • SOMBRA Warm Pain Relieving Gel Topical Product SBDG · 1184182
  • Sore No More Topical Product SBDG · 1372558
  • SOMBRA Warm Pain Relieving Gel BN · 1090951
  • Sore No More BN · 1372555

📦 FDA Products & Package NDCs

6 products · 20 package NDCs
20 package NDCs map to RxCUI 630714 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
61577-2280-02 58.7 g in 1 JAR (61577-2280-2) SORE NO MORE SOMBRA COSMETICS INC. 2016-10-25
61577-2280-04 113.4 g in 1 JAR (61577-2280-4) SORE NO MORE SOMBRA COSMETICS INC. 2016-10-25
61577-2280-05 5 g in 1 POUCH (61577-2280-5) SORE NO MORE SOMBRA COSMETICS INC. 2016-10-25
61577-2280-06 18200 g in 1 PAIL (61577-2280-6) SORE NO MORE SOMBRA COSMETICS INC. 2026-03-20
61577-2280-08 226.8 g in 1 JAR (61577-2280-8) SORE NO MORE SOMBRA COSMETICS INC. 2016-10-25
61577-2301-02 56.7 g in 1 TUBE (61577-2301-2) MUSCLE EASE SOMBRA COSMETICS INC. 2014-02-21
61577-2301-04 113.4 g in 1 JAR (61577-2301-4) MUSCLE EASE SOMBRA COSMETICS INC. 2014-02-21
61577-3234-02 907.2 g in 1 BOTTLE, PUMP (61577-3234-2) SORE NO MORE WARM THERAPY SOMBRA COSMETICS INC. 2016-06-14
61577-3234-03 226.8 g in 1 JAR (61577-3234-3) SORE NO MORE WARM THERAPY SOMBRA COSMETICS INC. 2016-06-14
61577-3234-04 113.4 g in 1 JAR (61577-3234-4) SORE NO MORE WARM THERAPY SOMBRA COSMETICS INC. 2016-06-14
61577-3234-05 85 g in 1 BOTTLE, PLASTIC (61577-3234-5) SORE NO MORE WARM THERAPY SOMBRA COSMETICS INC. 2016-06-14
61577-3234-06 113.4 g in 1 TUBE (61577-3234-6) SORE NO MORE WARM THERAPY SOMBRA COSMETICS INC. 2016-06-14
61577-3234-07 56.7 g in 1 JAR (61577-3234-7) SORE NO MORE WARM THERAPY SOMBRA COSMETICS INC. 2016-06-14
61577-3234-08 28.3 g in 1 PACKAGE (61577-3234-8) SORE NO MORE WARM THERAPY SOMBRA COSMETICS INC. 2017-06-01
61577-3234-09 5 g in 1 POUCH (61577-3234-9) SORE NO MORE WARM THERAPY SOMBRA COSMETICS INC. 2016-06-14
61577-7365-01 5 g in 1 PACKET (61577-7365-1) PAIN NO MORE THERAPY SOMBRA COSMETICS INC. 2018-05-13
61577-7365-04 113.4 g in 1 JAR (61577-7365-4) PAIN NO MORE THERAPY SOMBRA COSMETICS INC. 2018-05-13
61577-7365-05 113.4 g in 1 TUBE (61577-7365-5) PAIN NO MORE THERAPY SOMBRA COSMETICS INC. 2018-05-13
72835-0701-02 1 KIT in 1 CARTON (72835-701-02) * 60 TABLET, DELAYED RELE... Inflatherm V2 Pharma, LLC 2024-08-13
85622-0510-85 85 g in 1 BOTTLE, WITH APPLICATOR (85622-510-85) NeuroSoothe Blue Heron Pharmaceuticals, LLC 2026-02-23
Observed labelers: SOMBRA COSMETICS INC. (18) · Blue Heron Pharmaceuticals, LLC (1) · V2 Pharma, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.